135 related articles for article (PubMed ID: 31350847)
21. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
Front Genet; 2021; 12():692953. PubMed ID: 34490033
[No Abstract] [Full Text] [Related]
22. Topologically inferring pathway activity for precise survival outcome prediction: breast cancer as a case.
Liu W; Wang W; Tian G; Xie W; Lei L; Liu J; Huang W; Xu L; Li E
Mol Biosyst; 2017 Feb; 13(3):537-548. PubMed ID: 28098303
[TBL] [Abstract][Full Text] [Related]
23. Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
Bai J; Zhang X; Xiang ZX; Zhong PY; Xiong B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1134-1141. PubMed ID: 32096169
[TBL] [Abstract][Full Text] [Related]
24. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
25. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
[TBL] [Abstract][Full Text] [Related]
26. A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma.
Zhou C; Zhao Y; Yin Y; Hu Z; Atyah M; Chen W; Meng Z; Mao H; Zhou Q; Tang W; Wang P; Li Z; Weng J; Bruns C; Popp M; Popp F; Dong Q; Ren N
Int J Biol Sci; 2019; 15(11):2282-2295. PubMed ID: 31595147
[TBL] [Abstract][Full Text] [Related]
27. Comparison of variable selection methods for high-dimensional survival data with competing events.
Gilhodes J; Zemmour C; Ajana S; Martinez A; Delord JP; Leconte E; Boher JM; Filleron T
Comput Biol Med; 2017 Dec; 91():159-167. PubMed ID: 29078093
[TBL] [Abstract][Full Text] [Related]
28. GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer.
Zhu X; Tian X; Sun T; Yu C; Cao Y; Yan T; Shen C; Lin Y; Fang JY; Hong J; Chen H
Mol Oncol; 2018 Nov; 12(11):1871-1883. PubMed ID: 29957874
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
[TBL] [Abstract][Full Text] [Related]
30. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
31. A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.
Chang WH; Forde D; Lai AG
J Transl Med; 2019 Jan; 17(1):14. PubMed ID: 30626396
[TBL] [Abstract][Full Text] [Related]
32. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ
Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294
[TBL] [Abstract][Full Text] [Related]
33. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
34. Decentralized Learning Framework of Meta-Survival Analysis for Developing Robust Prognostic Signatures.
Cui Y; Li B; Li R
JCO Clin Cancer Inform; 2017 Nov; 1():1-13. PubMed ID: 30657395
[TBL] [Abstract][Full Text] [Related]
35. Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models.
Zemmour C; Bertucci F; Finetti P; Chetrit B; Birnbaum D; Filleron T; Boher JM
Cancer Inform; 2015; 14(Suppl 2):129-38. PubMed ID: 25983547
[TBL] [Abstract][Full Text] [Related]
36. Comparison of pathway and gene-level models for cancer prognosis prediction.
Zheng X; Amos CI; Frost HR
BMC Bioinformatics; 2020 Feb; 21(1):76. PubMed ID: 32111152
[TBL] [Abstract][Full Text] [Related]
37. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
38. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Zengin T; Önal-Süzek T
BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
[TBL] [Abstract][Full Text] [Related]
39. Novel gene signatures for prognosis prediction in ovarian cancer.
Bao M; Zhang L; Hu Y
J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
[TBL] [Abstract][Full Text] [Related]
40. The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction.
Tan Z; Lei Y; Xu J; Shi S; Hua J; Zhang B; Meng Q; Liu J; Zhang Y; Wei M; Yu X; Liang C
Aging (Albany NY); 2020 Nov; 12(23):24228-24241. PubMed ID: 33226369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]